Does Omega-3 Really Improve Focus? What Research Says

What does the latest meta-analysis actually find?

The most relevant recent evidence comes from a 2025 systematic review and dose-response meta-analysis of 58 randomised controlled trials in adults¹. The researchers estimated the change in cognitive function for each 2,000 mg/day increase in omega-3 supplementation.

For attention specifically, they reported a standardised mean difference (SMD) of 0.98, with a 95% confidence interval of 0.41 to 1.54¹. That is a large effect by conventional standards, but the GRADE certainty rating was low. Low certainty means the true effect could be meaningfully different from the estimate, usually because of inconsistency between trials, imprecision, or risk of bias.

The same analysis found improvements in perceptual speed (SMD 0.50), language (SMD 0.98), primary memory (SMD 0.87), visuospatial function (SMD 0.86) and global cognitive abilities (SMD 1.08)¹. Episodic memory showed a non-linear dose-response pattern, initially decreasing with higher doses before appearing to increase¹.

If you are unfamiliar with what an SMD of 0.98 means in practical terms, our plain guide to effect size explains how to read these numbers.

Why the headline number overstates the real-world effect

A large pooled effect size with a low GRADE rating deserves caution. Several things can inflate pooled estimates in this area.

First, the confidence interval for attention was wide: 0.41 to 1.54¹. That spans a modest benefit through to an implausibly large one. Wide intervals often reflect small trials with variable methods.

Second, publication bias is a known problem in supplement research. Trials showing no effect are less likely to be published, which can make pooled estimates look better than the true effect. Our explainer on publication bias covers how this works.

Third, the dose-response analysis suggests the relationship between omega-3 dose and some cognitive outcomes is not linear. More is not automatically better, and the optimal dose for attention remains unclear¹.

What happened when researchers tested omega-3 in Alzheimer's disease?

Two large randomised controlled trials tested whether omega-3 could slow cognitive decline in people with mild to moderate Alzheimer's disease. Both found no overall benefit.

A 2010 US trial randomised 402 people with mild to moderate Alzheimer's to 2 g/day of algal DHA or placebo for 18 months. Cognitive decline on the ADAS-cog scale was nearly identical between groups: 7.98 points for DHA versus 8.27 for placebo². Brain atrophy rates also did not differ².

An earlier 2006 Swedish trial, the OmegAD study, gave 1.7 g DHA plus 0.6 g EPA daily to 174 people with Alzheimer's for six months. Overall cognitive decline did not differ between groups, though a small subgroup of 32 people with very mild impairment showed a significant benefit³.

These trials do not answer the question of whether omega-3 helps focus in healthy adults. But they are a useful reminder that a nutrient with plausible brain mechanisms does not always produce measurable cognitive improvements in well-designed trials. For more on why trial design matters, see our guide to randomised controlled trials.

What about people with stress, anxiety or memory complaints?

A 2026 randomised, double-blind, placebo-controlled trial in Saudi Arabia tested omega-3 in 64 adults with severe psychological distress⁴. Participants took 500 mg EPA plus 250 mg DHA daily, or placebo, for three months.

The omega-3 group showed significant improvements in stress, anxiety, depression, sleep quality and memory outcomes on validated questionnaires⁴. The study authors suggest omega-3 may work as an adjunct for managing stress and mood disturbances, and note that baseline inflammation and omega-3 status could influence individual responses⁴.

This is a small trial with a specific population, so its findings do not generalise to everyone. But it suggests that people experiencing high psychological distress may be more likely to notice cognitive and mood benefits than healthy adults with normal baseline function.

Does omega-3 help with ADHD?

The evidence on omega-3 for ADHD is less settled than supplement marketing often implies. A 2026 systematic review and meta-analysis of 18 randomised controlled trials in children and adolescents with ADHD compared pharmacological and non-pharmacological treatments⁵.

Stimulant medications consistently reduced ADHD symptoms, though effects on academic performance were modest. Non-stimulant medications such as viloxazine and guanfacine produced statistically significant but clinically modest improvements. The review notes that some nutritional supplements, particularly iron and omega-3 fatty acids, showed benefits in symptom reduction⁵.

However, the abstract does not report a pooled effect size for omega-3 specifically, and the comparison is against medications with well-established efficacy. The honest reading is that omega-3 may offer some benefit for some people with ADHD, but the evidence base is smaller and less consistent than for first-line treatments.

Is there a specific group where omega-3 matters more?

A 2025 narrative review on omega-3 and brain health during the menopausal transition argues that this period may be a critical window for intervention⁶. The review notes that declining oestrogen is linked to transient cognitive deficits, disrupted sleep and mood changes, and that the brain is enriched in DHA⁶.

The author describes the evidence as "relatively sparse" but "indicative of benefit", and calls for future randomised trials to establish dose-response relationships and optimal timing⁶. A narrative review is expert opinion rather than primary evidence, so this should be read as a research direction rather than a settled finding.

What to do this week

If you want to test whether omega-3 supports your focus, keep expectations calibrated and your approach simple.

First, treat it as a long-term experiment, not an acute fix. The trial that found everyday memory benefits ran for three months⁴, and the meta-analysis looked at supplementation over weeks to months¹.

Second, choose a product that clearly states its EPA and DHA content. Fish-oil supplements that supply EPA and DHA are widely available, including omega-3 fish oil options. If you already buy from sports-nutrition brands, both Bulk and Myprotein sell omega-3 alongside their core ranges.

Third, check with your GP or pharmacist before starting if you take medication, are pregnant or have a health condition. Omega-3 supplements can interact with anticoagulant medicines, and this is not something to self-manage.

Finally, if focus problems are persistent and interfering with work or study, speak to a GP. Persistent attention difficulties can have underlying causes that a supplement will not address.